Dinoprostone 3 mg
Dinoprostone 3 mg is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
Single-dose Vaginal Dinoprostone and Hysterectomy
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy
Clinical Trials (7)
Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy
Gemeprost Versus Dinoprostone in First Trimester Miscarriages
Single-dose Vaginal Dinoprostone and Hysterectomy
Vaginal Dinoprostone Administration Prior to a T380A Intrauterine Device Insertion in Nulliparous Women.
Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy
Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery
Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7